Francois Nader

Insider Reports History

Entity
Individual
Location
550 Hills Drive, Bedminster, NJ
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Francois Nader:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Talaris Therapeutics, Inc. Director Stock Option (Right to Buy) 41K Jun 13, 2023 Direct
Moderna, Inc. Director Stock Option (Right to Buy) 7.56K May 6, 2024 Direct
ACCELERON PHARMA INC Director Common Stock 0 $29.37 Nov 19, 2021 Direct
ACCELERON PHARMA INC Director Option to Purchase Common Stock 0 Nov 19, 2021 Direct
ALEXION PHARMACEUTICALS, INC. Director Common Stock, par value $.0001 per share 0 $177.00 Jul 21, 2021 Direct

Insider Reports Filed by Francois Nader

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRNA Moderna, Inc. May 6, 2024 1 $0 4 May 7, 2024 Director
TALS Talaris Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 14, 2023 Director
MRNA Moderna, Inc. May 3, 2023 1 $0 4 May 5, 2023 Director
TALS Talaris Therapeutics, Inc. Jul 19, 2022 7 $500K 4/A Sep 13, 2022 Director
TALS Talaris Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
MRNA Moderna, Inc. May 10, 2022 3 $921 4 May 12, 2022 Director
MRNA Moderna, Inc. Apr 28, 2022 3 $0 4 May 2, 2022 Director
TALS Talaris Therapeutics, Inc. Dec 15, 2021 1 $0 4 Dec 16, 2021 Director
XLRN ACCELERON PHARMA INC Nov 19, 2021 10 $0 4 Nov 22, 2021 Director
ALXN ALEXION PHARMACEUTICALS, INC. Jul 21, 2021 1 $0 4 Jul 23, 2021 Director
ALXN ALEXION PHARMACEUTICALS, INC. May 20, 2021 2 $0 4 May 24, 2021 Director